Sulfonyl urea and carbamate ACAT inhibitors
    31.
    发明授权
    Sulfonyl urea and carbamate ACAT inhibitors 失效
    磺酰脲和氨基甲酸酯ACAT抑制剂

    公开(公告)号:US5254589A

    公开(公告)日:1993-10-19

    申请号:US776112

    申请日:1991-10-15

    CPC分类号: C07C311/53 C07C311/55

    摘要: A pharmaceutically useful compound which lowers blood cholesterol levels having the formula ##STR1## wherein X is oxygen or --NH--; Ar is phenyl, substituted phenyl, naphthyl or substituted naphthyl; R.sub.1 is hydrogen, lower alkyl or benzyl; and R.sub.2 is a straight or branched alkyl group having from 5 to 17 carbon atoms which may be substituted on the 1-carbon position with methyl, ethyl, phenyl, or substituted phenyl, or a cycloalkyl group having from 3 to 8 carbon atoms.

    摘要翻译: 降低具有式“IMAGE”的血液胆固醇水平的药学上有用的化合物,其中X是氧或-NH-; Ar是苯基,取代的苯基,萘基或取代的萘基; R1是氢,低级烷基或苄基; 并且R 2是具有5至17个碳原子的直链或支链烷基,其可以在1-碳位上被甲基,乙基,苯基或取代的苯基或具有3至8个碳原子的环烷基取代。

    Process for trans-6-(2-substituted-pyrrol-1-yl)alkyl)pyran-2-one
inhibitors of cholesterol synthesis
    32.
    发明授权
    Process for trans-6-(2-substituted-pyrrol-1-yl)alkyl)pyran-2-one inhibitors of cholesterol synthesis 失效
    反式-6-(2-取代 - 吡咯-1-基)烷基)吡喃-2-酮胆固醇合成抑制剂的方法

    公开(公告)号:US5124482A

    公开(公告)日:1992-06-23

    申请号:US792311

    申请日:1991-11-14

    摘要: An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien-4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans(.+-.)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide by a novel synthesis where 4-methyl-3-oxo-N-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2-methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenzenebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.

    摘要翻译: 描述了通过新的合成制备反式-6- [2-(取代的 - 吡咯-1-基)烷基]吡喃-2-酮的改进方法,其中将1,6-庚二烯-4-醇转化为8 (2R-反式)和反式(+/-) - 5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基的改进方法 -1- [2-(四氢-4-羟基-6-氧代-2H-吡喃-2-基)乙基] -1H-吡咯-3-甲酰胺的新型合成法,其中4-甲基-3-氧代-N - 苯基戊酰胺在八个操作中转化成所需产物,或者4-氟-α-[2-甲基-1-氧代丙基]-γ-氧代-N,β-二苯基苯丁酰胺在一个步骤中转化成所需产物,另外 ,制备(2R-反式)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1- [2-(四氢-4-羟基-6-氧代 - (R)-4-氰基-3 - [[(1,1-二甲基乙基)二甲基甲硅烷基]氧基]丁酸,以及其它有价值的(R)-4-氰基-3 - [(1H-吡喃-2-基)乙基] -1H-吡咯-3-甲酰胺 中间体 的过程。

    Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one
inhibitors of cholesterol synthesis
    33.
    发明授权
    Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis 失效
    反式-6- [2-(取代 - 吡咯-1-基)烷基]吡喃-2-酮胆固醇合成抑制剂的方法

    公开(公告)号:US5097045A

    公开(公告)日:1992-03-17

    申请号:US595461

    申请日:1990-10-09

    摘要: An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien-4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans-(.+-.)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]1H-pyrrole-3-carboxamide by a novel synthesis where 4-methyl-3-oxo-N-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-.alpha.-[2-methyl-1-oxopropyl]-.gamma.-oxo-N,.beta.-diphenylbenzenebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.

    摘要翻译: 描述了通过新的合成制备反式-6- [2-(取代的 - 吡咯-1-基)烷基]吡喃-2-酮的改进方法,其中将1,6-庚二烯-4-醇转化为8 (2R-反式)和反 - (+/-) - 5-(4-氟苯基)-2-(1-甲基乙基)-N,4- 二苯基-1- [2-(叔 - 羟基-6-羟基-6-氧代-2H-吡喃-2-基)乙基] -1H-吡咯-3-甲酰胺,通过新的合成法,其中4-甲基-3-氧代-N - 苯基戊酰胺在八个操作中转化成所需产物,或者4-氟-α-[2-甲基-1-氧代丙基]-γ-氧代-N,β-二苯基苯丁酰胺在一个步骤中转化成所需产物,另外 ,制备(2R-反式)-5-(4-氟苯基)-2-(1-甲基乙基)-N,4-二苯基-1- [2-(四氢-4-羟基-6-氧代 - (R)-4-氰基-3 - [[(1,1-二甲基乙基)二甲基甲硅烷基]氧基]丁酸,以及其它有价值的(R)-4-氰基-3 - [(1H-吡喃-2-基)乙基] 中间体使用 d在进程中。

    Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol
synthesis
    34.
    发明授权
    Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis 失效
    双环庚烷和双环辛烷基取代的胆固醇合成抑制剂

    公开(公告)号:US4957940A

    公开(公告)日:1990-09-18

    申请号:US439719

    申请日:1989-11-21

    申请人: Bruce D. Roth

    发明人: Bruce D. Roth

    CPC分类号: C07D309/30 Y10S514/824

    摘要: Certain bicyclo [2.2.1] heptane and bicyclo [2.2.2] octane substituted tetrahydro-2H-pyran-2-ones and the corresponding ring-opened acids derived therefrom are potent inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) and are useful as hypocholesterolemic and hypolipidemic agents.

    摘要翻译: 某些双环[2.2.1]庚烷和双环[2.2.2]辛烷取代的四氢-2H-吡喃-2-酮及其衍生的相应的开环酸是3-羟基-3-甲基戊二酰辅酶3的有效抑制剂 还原酶(HMG-CoA还原酶),可用作低胆固醇血症和降血脂药。